1. A Phase II Trial of Cabozantinib in Hormone Receptor‐Positive Breast Cancer with Bone Metastases. (18th June 2020) Authors: Xu, Jing; Higgins, Michaela J.; Tolaney, Sara M.; Come, Steven E.; Smith, Matthew R.; Fornier, Monica; Mahmood, Umar; Baselga, Jose; Yeap, Beow Y.; Chabner, Bruce A.; Isakoff, Steven J. Journal: Oncologist Issue: Volume 25:Number 8(2020) Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Denosumab and fracture risk in women with breast cancer. Issue 10008 (21st November 2015) Authors: Farooki, Azeez; Fornier, Monica Journal: Lancet Issue: Volume 386:Issue 10008(2015) Page Start: 2056 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Eribulin mesylate in patients with locally advanced unresectable or metastatic breast cancer: results and implications of the clinical trials. (May 2015) Authors: Ramnaraign, Brian; Page, David; Fornier, Monica Journal: Breast cancer management Issue: Volume 4:Number 3(2015) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Eribulin mesylate in patients with locally advanced unresectable or metastatic breast cancer: results and implications of the clinical trials. (May 2015) Authors: Ramnaraign, Brian; Page, David; Fornier, Monica Journal: Breast cancer management Issue: Volume 4:Number 3(2015) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Issue 9 (September 2019) Authors: Saura, Cristina; Hlauschek, Dominik; Oliveira, Mafalda; Zardavas, Dimitrios; Jallitsch-Halper, Anita; de la Peña, Lorena; Nuciforo, Paolo; Ballestrero, Alberto; Dubsky, Peter; Lombard, Janine M; Vuylsteke, Peter; Castaneda, Carlos A; Colleoni, Marco; Santos Borges, Giuliano; Ciruelos, Eva; Fornie... Journal: Lancet oncology Issue: Volume 20:Issue 9(2019) Page Start: 1226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients. Issue 3 (March 2016) Authors: Owosho, Adepitan A.; Blanchard, Ariel; Levi, Lauren; Kadempour, Arvin; Rosenberg, Haley; Yom, SaeHee K.; Farooki, Azeez; Fornier, Monica; Huryn, Joseph M.; Estilo, Cherry L. Journal: Journal of cranio-maxillofacial surgery Issue: Volume 44:Issue 3(2016) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study. Issue 1 (10th August 2014) Authors: Tenori, Leonardo; Oakman, Catherine; Morris, Patrick G.; Gralka, Ewa; Turner, Natalie; Cappadona, Silvia; Fornier, Monica; Hudis, Cliff; Norton, Larry; Luchinat, Claudio; Di Leo, Angelo Journal: Molecular oncology Issue: Volume 9:Issue 1(2015:Jan.) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗